Social Capital: Two Case Studies of Chinese Small Business in the Greater Phoenix and Los Angeles Areas
Drawing upon the data from in-depth interviews and informal observations, this dissertation was guided by three research questions: (a) What barriers do immigrant small business owners encounter? (b) What social connections provide help for immigrant small business owners to overcome those barriers or intensify their disadvantaged situations? (c) How do social networks influence immigrant small business development? The findings revealed many provocative facts on how social capital stimulated Chinese immigrant small business owners.
The influence of local and strong ties especially provided essential start-up funds, an affordable labor force. Those ties also provided authentication for business information provided by weak ties. Although the governments’ Small Business Administration empowers small business by various programs because it is an important social and economic element in the U.S. market, the Chinese community rarely utilized this support.
Transnational connections played an important role in the relatively mature market found in Los Angeles, but indeed all respondents in both case studies exhibited great interest in utilizing transnational connections to explore business opportunities. Regional connections provided a powerful resource for Chinese small business to create business alliance and increase their market competitiveness. Social capital embeds in a complexity of political, economic, social and personal backgrounds. In summary, social capital was an essential resource for Chinese small business when they encountered the barriers in the local market. From the findings, this dissertation’s scholarly contribution adds to the field of social capital studies by combining the investigation of social capital, embeddedness, intersectionality and transnational connections in respect to study immigrant entrepreneurship.
- Author (aut): Kwoh, Jing Yu Xin Yu Xiao
- Thesis advisor (ths): Jurik, Nancy
- Committee member: Li, Wei
- Committee member: Johnson, John
- Publisher (pbl): Arizona State University
Enhanced Immunity in a Mouse Model of Malignant Glioma is Mediated by a Therapeutic Ketogenic Diet
Background: Glioblastoma multiforme is a highly aggressive brain tumor with a poor prognosis, and advances in treatment have led to only marginal increases in overall survival. We and others have shown previously that the therapeutic ketogenic diet (KD) prolongs survival in mouse models of glioma, explained by both direct tumor growth inhibition and suppression of pro-inflammatory microenvironment conditions. The aim of this study is to assess the effects of the KD on the glioma reactive immune response.
Methods: The GL261-Luc2 intracranial mouse model of glioma was used to investigate the effects of the KD on the tumor-specific immune response. Tumor-infiltrating CD8+ T cells, CD4+ T cells and natural killer (NK) cells were analyzed by flow cytometry. The expression of immune inhibitory receptors cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death 1 (PD-1) on CD8+ T cells were also analyzed by flow cytometry. Analysis of intracellular cytokine production was used to determine production of IFN, IL-2 and IFN- in tumor-infiltrating CD8+ T and natural killer (NK) cells and IL-10 production by T regulatory cells.
Results: We demonstrate that mice fed the KD had increased tumor-reactive innate and adaptive immune responses, including increased cytokine production and cytolysis via tumor-reactive CD8+ T cells. Additionally, we saw that mice maintained on the KD had increased CD4 infiltration, while T regulatory cell numbers stayed consistent. Lastly, mice fed the KD had a significant reduction in immune inhibitory receptor expression as well as decreased inhibitory ligand expression on glioma cells.
Conclusions: The KD may work in part as an immune adjuvant, boosting tumor-reactive immune responses in the microenvironment by alleviating immune suppression. This evidence suggests that the KD increases tumor-reactive immune responses, and may have implications in combinational treatment approaches.
- Author (aut): Lussier, Danielle
- Author (aut): Woolf, Eric
- Author (aut): Johnson, John
- Author (aut): Brooks, Kenneth S.
- Author (aut): Blattman, Joseph
- Author (aut): Scheck, Adrienne
- Contributor (ctb): ASU Biodesign Center Immunotherapy, Vaccines and Virotherapy
- Contributor (ctb): College of Liberal Arts and Sciences
Combination Immunotherapy with α-CTLA-4 and α-PD-L1 Antibody Blockade Prevents Immune Escape and Leads to Complete Control of Metastatic Osteosarcoma
Background: Osteosarcoma is one of the most common bone cancers in children. Most patients with metastatic osteosarcoma die of pulmonary disease and limited curative therapeutic options exist for such patients. We have previously shown that PD-1 limits the efficacy of CTL to mediate immune control of metastatic osteosarcoma in the K7M2 mouse model of pulmonary metastatic disease and that blockade of PD-1/PD-L1 interactions can partially improve survival outcomes by enhancing the function of osteosarcoma-specific CTL. However, PD-1/PD-L1 blockade-treated mice eventually succumb to disease due to selection of PD-L1 mAb-resistant tumor cells. We investigated the mechanism of tumor cell resistance after blockade, and additional combinational therapies to combat resistance.
Methods: We used an implantable model of metastatic osteosarcoma, and evaluated survival using a Log-rank test. Cellular analysis of the tumor was done post-mortem with flow cytometry staining, and evaluated using a T-test to compare treatment groups.
Results: We show here that T cells infiltrating PD-L1 antibody-resistant tumors upregulate additional inhibitory receptors, notably CTLA-4, which impair their ability to mediate tumor rejection. Based on these results we have tested combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade in the K7M2 mouse model of metastatic osteosarcoma and show that this results in complete control of tumors in a majority of mice as well as immunity to further tumor inoculation.
Conclusions: Thus, combinational immunotherapy approaches to block additional inhibitory pathways in patients with metastatic osteosarcoma may provide new strategies to enhance tumor clearance and resistance to disease.
- Author (aut): Lussier, Danielle
- Author (aut): Johnson, John
- Author (aut): Hingorani, Pooja
- Author (aut): Blattman, Joseph
- Contributor (ctb): ASU Biodesign Center Immunotherapy, Vaccines and Virotherapy
- Contributor (ctb): College of Liberal Arts and Sciences
Who must die: the state of exception in Rwanda's genocide
- Author (aut): Sinema, Kyrsten
- Thesis advisor (ths): Johnson, John
- Committee member: Quan, Helen
- Committee member: Gomez, Alan
- Committee member: Doty, Roxanne
- Publisher (pbl): Arizona State University
First love, then marriage, then a baby carriage?
- Author (aut): Ross, Jane
- Thesis advisor (ths): Johnson, John
- Committee member: Hepburn, John
- Committee member: Stinson, Judith
- Publisher (pbl): Arizona State University
From criminalization to symbolic resiliency: undocumented immigrants "re-imagining success" In the United States
- Author (aut): Alatorre, Francisco Jesus
- Thesis advisor (ths): Johnson, John
- Committee member: Zatz, Marjorie
- Committee member: Ashford, Jose
- Publisher (pbl): Arizona State University